176 related articles for article (PubMed ID: 8089857)
1. In vivo gene therapy of human lung cancer using wild-type p53 delivered by retrovirus.
Carbone DP; Minna JD
J Natl Cancer Inst; 1994 Oct; 86(19):1437-8. PubMed ID: 8089857
[No Abstract] [Full Text] [Related]
2. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.
Roth JA; Nguyen D; Lawrence DD; Kemp BL; Carrasco CH; Ferson DZ; Hong WK; Komaki R; Lee JJ; Nesbitt JC; Pisters KM; Putnam JB; Schea R; Shin DM; Walsh GL; Dolormente MM; Han CI; Martin FD; Yen N; Xu K; Stephens LC; McDonnell TJ; Mukhopadhyay T; Cai D
Nat Med; 1996 Sep; 2(9):985-91. PubMed ID: 8782455
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model.
Fujiwara T; Cai DW; Georges RN; Mukhopadhyay T; Grimm EA; Roth JA
J Natl Cancer Inst; 1994 Oct; 86(19):1458-62. PubMed ID: 8089864
[TBL] [Abstract][Full Text] [Related]
4. Preparation of retroviral vectors for cell-cycle-targeted gene therapy of lung cancer.
Claudio PP; Giordano A
Methods Mol Med; 2003; 75():591-605. PubMed ID: 12407766
[No Abstract] [Full Text] [Related]
5. Aerosol gene therapy for metastatic lung cancer using PEI-p53 complexes.
Gautam A; Waldrep JC; Kleinerman ES; Xu B; Fung YK; T'Ang A; Densmore CL
Methods Mol Med; 2003; 75():607-18. PubMed ID: 12407767
[No Abstract] [Full Text] [Related]
6. p53 Gene therapy for lung cancer.
Swisher SG; Roth JA
Curr Oncol Rep; 2002 Jul; 4(4):334-40. PubMed ID: 12044243
[TBL] [Abstract][Full Text] [Related]
7. [Gene therapy with wild-type p53 in lung tumors].
Dunst J
Strahlenther Onkol; 1997 Aug; 173(8):431-2. PubMed ID: 9289861
[No Abstract] [Full Text] [Related]
8. p53 trans-dominantly suppresses tumor formation of human breast cancer cells mediated by retroviral bulk infection without marker gene selection: an expeditious in vitro protocol with implications towards gene therapy.
Runnebaum IB; Kreienberg R
Hybridoma; 1995 Apr; 14(2):153-7. PubMed ID: 7590773
[TBL] [Abstract][Full Text] [Related]
9. Identifying obstacles to viral gene therapy for lung cancer. Malignant pleural effusions as a paradigm.
Batra RK; Bernal RM; Sharma S
Methods Mol Med; 2003; 75():545-59. PubMed ID: 12407763
[No Abstract] [Full Text] [Related]
10. Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer.
Cai DW; Mukhopadhyay T; Liu Y; Fujiwara T; Roth JA
Hum Gene Ther; 1993 Oct; 4(5):617-24. PubMed ID: 8280799
[TBL] [Abstract][Full Text] [Related]
11. A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer.
Schuler M; Rochlitz C; Horowitz JA; Schlegel J; Perruchoud AP; Kommoss F; Bolliger CT; Kauczor HU; Dalquen P; Fritz MA; Swanson S; Herrmann R; Huber C
Hum Gene Ther; 1998 Sep; 9(14):2075-82. PubMed ID: 9759934
[TBL] [Abstract][Full Text] [Related]
12. Cancer gene therapy mediated by CTS1, a p53 derivative: advantage over wild-type p53 in growth inhibition of human tumors overexpressing MDM2.
Bougeret C; Virone-Oddos A; Adeline E; Lacroix F; Lefranc C; Ferrero L; Huet T
Cancer Gene Ther; 2000 May; 7(5):789-98. PubMed ID: 10830726
[TBL] [Abstract][Full Text] [Related]
13. Anti-oncogene and tumor suppressor gene therapy--examples from a lung cancer animal model.
Zhang WW; Roth JA
In Vivo; 1994; 8(5):755-69. PubMed ID: 7727723
[TBL] [Abstract][Full Text] [Related]
14. Retrovirus-mediated p53 gene therapy.
Estreicher A; Iggo R
Nat Med; 1996 Nov; 2(11):1163. PubMed ID: 8898732
[No Abstract] [Full Text] [Related]
15. Efficient retrovirus-mediated transfer of cell-cycle control genes to transformed cells.
Strauss BE; Costanzi-Strauss E
Braz J Med Biol Res; 1999 Jul; 32(7):905-14. PubMed ID: 10454751
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer.
Nguyen DM; Spitz FR; Yen N; Cristiano RJ; Roth JA
J Thorac Cardiovasc Surg; 1996 Nov; 112(5):1372-6; discussion 1376-7. PubMed ID: 8911337
[TBL] [Abstract][Full Text] [Related]
17. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model.
Ko SC; Gotoh A; Thalmann GN; Zhau HE; Johnston DA; Zhang WW; Kao C; Chung LW
Hum Gene Ther; 1996 Sep; 7(14):1683-91. PubMed ID: 8886839
[TBL] [Abstract][Full Text] [Related]
18. [Recombinant virus-mediated transfer of the wild-type p53 gene is a potent therapeutic strategy for human cancer].
Fujiwara T; Kagawa S; Ogawa N; Yasuda T; Tanaka N; Orita K; Cai DW; Zhang WW; Roth JA
Hum Cell; 1996 Mar; 9(1):25-30. PubMed ID: 9183626
[TBL] [Abstract][Full Text] [Related]
19. Clinical update of Ad-p53 gene therapy for lung cancer.
Swisher SG; Roth JA
Surg Oncol Clin N Am; 2002 Jul; 11(3):521-35. PubMed ID: 12487055
[TBL] [Abstract][Full Text] [Related]
20. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis.
Fujiwara T; Grimm EA; Mukhopadhyay T; Cai DW; Owen-Schaub LB; Roth JA
Cancer Res; 1993 Sep; 53(18):4129-33. PubMed ID: 8395976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
